6505--Eszopiclone Tablets
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the NAC PHARMACEUTICALS (36E797) office, has awarded a contract to GOLDEN STATE MEDICAL SUPPLY, INC. for the supply of Eszopiclone Tablets. The award, identified as 36E79726D0018, was made on January 29, 2026, with a total value of $5,537,389.48.
Scope of Work
This contract secures the supply of Eszopiclone tablets in 1mg, 2mg, and 3mg strengths for the VA and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs. The objective is to ensure nationwide availability of these drugs and obtain volume-based pricing. Key requirements included FDA approval, manufacturing in cGMP acceptable facilities, unique 11-digit National Drug Codes (NDC), bar code labeling, and compliance with the Drug Supply Chain Security Act (DSCSA). Products were required to be packaged in 30-tablet bottles with specific dimensions and safety cap features.
Contract Details
- Awardee: GOLDEN STATE MEDICAL SUPPLY, INC. (UEI: GQLDJJ8AQNN5)
- Award Number: 36E79726D0018
- Award Date: January 29, 2026
- Total Award Value: $5,537,389.48
- Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements contract
- Period of Performance: Base year plus four one-year option periods
- Set-Aside: Unrestricted
- Product Service Code: 6505 (Drugs And Biologicals)
Evaluation & Requirements
The original solicitation was evaluated based on the Lowest Price Technically Acceptable (LPTA) methodology. Technical acceptability criteria included meeting product descriptions, NDC uniqueness, FDA approval, cGMP compliance, and manufacturing facility clearance.
Contact Information
For inquiries regarding this award, the primary point of contact is Richard Mahario, Contract Specialist, at Richard.Mahario@va.gov or 708-786-5247.